research HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
This study observed that while PrEP was effective among transgender women if taken, adherence was low, especially among those at higher risk.
Search
forResearch
5 / 1000+ resultsresearch Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa
The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.
research РЕЗУЛЬТАТЫ БИОПОВЕДЕНЧЕСКОГО ИССЛЕДОВАНИЯ СРЕДИ СЕКС-РАБОТНИКОВ ГОРОДА КОСТАНАЙ В 2024 ГОДУ
This study conducted among sex workers in Kostanay reported a low HIV prevalence of 0.8% but a high syphilis rate of 15.6%, highlighting significant social risks and emphasizing the need to expand pre-exposure prophylaxis and prevention programs.
research Challenges to PrEP use and perceptions of urine tenofovir adherence monitoring reported by individuals on PrEP
This study found that using urine tenofovir monitoring for PrEP adherence is well-accepted and may help overcome adherence barriers among participants at a U.S. urban clinical center.
research Editor’s picks January 2021
PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.
Community Join
1 / 1000+ resultscommunity Evolution theory: AGA is your body trying to reduce the risk of prostate cancer by exposing your scalp to more UV
Androgenic alopecia (AGA) might have evolved to reduce prostate cancer risk by increasing UV exposure to the scalp, but this theory is debated. Treatments like minoxidil and finasteride are used for AGA, though the exact causes and evolutionary reasons for hair loss are unclear.
Learn
— no results
Experts
— no results
Clinics
— no results